Markets
Leaderboard
Will the HVTN 705 (Imbokodo) study result in a successful vaccine against AIDS? Yes: real money —, play money 51% No: real money —, play money 49% Volume: real money 144.17461356, play money 56685.22892472 Bettors: real money 0, play money 538 Categories: Science, Transmissible Diseases, AIDS Related markets Ebola virus declared a Public Health Emergency by the WHO in 2026? (ID: 239903) Volume: real 125.4378526, play 12000 Bettors: real 2, play 0 Leading (real money): Ebola virus declared a Public Health Emergency by the WHO in 2026? 10% Leading (play money): Ebola virus declared a Public Health Emergency by the WHO in 2026? 10% Nipah virus declared a public health emergency by the WHO in 2026? (ID: 233776) Volume: real 100.27023053, play 14933.4347 Bettors: real 5, play 3 Leading (real money): Nipah virus declared a public health emergency by the WHO in 2026? 11% Leading (play money): Nipah virus declared a public health emergency by the WHO in 2026? 6% Antarctic sea ice minimum to decrease in 2027? (ID: 235045) Volume: real 500.15038449, play 50000.1 Bettors: real 5, play 2 Leading (real money): Antarctic sea ice minimum to decrease in 2027? 81% Leading (play money): Antarctic sea ice minimum to decrease in 2027? 81%

Will the HVTN 705 (Imbokodo) study result in a successful vaccine against AIDS?

Market Rules

A large trial for a vaccine against HIV, which is the virus responsible for AIDS, started in 5 countries in sub-Saharan Africa in late 2017. The study is officially called HVTN 705, or Imbokodo.

The vaccine requires 4 injections within a year, then researchers will follow up for the following two years to test whether the vaccine regimen works. Results for the vaccine study are expected by 2021.

If the vaccine meets the 50 percent threshold, it will be considered successful and this question will be resolved as "Yes".

Related Markets